Odyssey Health (ODYY) Liabilities and Shareholders Equity (2014 - 2026)
Odyssey Health (ODYY) posted quarterly Liabilities and Shareholders Equity of $373779.0 for Q2 2026, up 127.21% year-over-year from $164508.0 in Q2 2025, and down 48.18% quarter-over-quarter from $721304.0 in Q1 2026.
Odyssey Health (ODYY) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
Odyssey Health's Liabilities and Shareholders Equity history runs 13 years deep, the most recent figure standing at $373779.0 for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity rose 127.21% year-over-year to $373779.0; the TTM figure through Apr 2026 stood at $1.3 million (down 5.16% YoY), while the FY2025 annual figure was $49723.0, down 91.52% from the prior year.
- Liabilities and Shareholders Equity for Q2 2026 stood at $373779.0, down from $721304.0 in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $14.0 million in Q1 2024, with the low at $49723.0 in Q3 2025.
- The 5-year median for Liabilities and Shareholders Equity is $459620.0 (2023), against an average of $1.9 million.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity jumped 3014.39% in 2024, then tumbled 98.79% in 2025.
- Odyssey Health's Liabilities and Shareholders Equity stood at $867723.0 in 2022, then dropped by 29.47% to $612039.0 in 2023, then tumbled by 44.28% to $341045.0 in 2024, then plunged by 57.89% to $143622.0 in 2025, then jumped by 160.25% to $373779.0 in 2026.
- Business Quant data shows ODYY's Liabilities and Shareholders Equity at $373779.0 in Q2 2026, $721304.0 in Q1 2026, and $143622.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | 373,779.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 373,779.00 |
| Jan 31, 2026 | 721,304.00 |
| Oct 31, 2025 | 143,622.00 |
| Jul 31, 2025 | 49,723.00 |
| Apr 30, 2025 | 164,508.00 |
| Jan 31, 2025 | 266,866.00 |
| Oct 31, 2024 | 341,045.00 |
| Jul 31, 2024 | 586,146.00 |
| Apr 30, 2024 | 13.58 Mn |
| Jan 31, 2024 | 14.05 Mn |
| Oct 31, 2023 | 612,039.00 |
| Jul 31, 2023 | 455,793.00 |
| Apr 30, 2023 | 435,908.00 |
| Jan 31, 2023 | 463,447.00 |
| Oct 31, 2022 | 867,723.00 |
| Jul 31, 2022 | 569,677.00 |
| Apr 30, 2022 | 619,104.00 |
| Jan 31, 2022 | 334,215.00 |
| Oct 31, 2021 | 931,813.00 |
| Jul 31, 2021 | 610,533.00 |